Health Care [ 5/12 ] | Biotechnology [ 51/74 ]
NASDAQ | Common Stock
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer.
The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension.
It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration.
The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011.
Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 26 | -0.08 Increased by +46.67% | -0.06 Decreased by -33.33% |
| Mar 26, 26 | -0.08 Increased by +57.89% | -0.10 Increased by +20.00% |
| Nov 14, 25 | -0.13 Increased by +27.78% | -0.11 Decreased by -18.18% |
| Aug 14, 25 | -0.12 Increased by +40.00% | -0.16 Increased by +25.00% |
| May 15, 25 | -0.15 Increased by +21.05% | -0.11 Decreased by -36.36% |
| Mar 27, 25 | -0.19 Decreased by -18.75% | -0.16 Decreased by -18.75% |
| Nov 14, 24 | -0.18 Increased by +25.00% | -0.20 Increased by +10.00% |
| Aug 13, 24 | -0.20 Decreased by -33.33% | -0.16 Decreased by -25.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -5.05 M Increased by +47.61% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by -100.00% | -5.50 M Increased by +54.04% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -8.18 M Increased by +27.06% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -7.52 M Increased by +39.20% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -9.63 M Increased by +16.17% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 36.00 K Decreased by -55.00% | -11.97 M Decreased by -19.71% | Decreased by -33.24 K% Decreased by -166.01% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -11.22 M Decreased by -7.59% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -12.37 M Decreased by -35.74% | Decreased by N/A% Decreased by N/A% |